Phoenix backs early stage firms with £100m VC fund
Phoenix will expose investors to new asset class
Phoenix Group, the UK’s largest long-term savings and retirement business, has launched its first dedicated venture capital fund to invest in disruptive and early stage businesses.
With an initial allocation in excess of £100m, Phoenix Venture Capital Partners will allow Phoenix Life unit-linked and with-profits policyholders, to diversify into an asset class that has until now been largely reserved for institutional investors.
This is the first allocation to venture capital in the policyholder funds, and the first allocation to patient capital in the unit linked funds.
It will partner Aberdeen Standard Investments to invest mainly in disruptive and transformative early stage UK based start-ups and businesses pursuing an ESG approach within a number of sectors including fintech, green energy and healthcare.
The investments made through the newly created fund will help business to scale-up whilst giving them access to the expertise that they require.
James Mitchell, Head of Manager Oversight, Edinburgh-based Phoenix Group, said: “We are pleased to have made an initial allocation to Venture Capital for our policyholder funds, which we see as a key enabler to helping Build Britain Back Better whilst providing our policyholders with a diversified source of sustainable returns.
“The new Venture Capital fund will support Healthcare, Green Energy and FinTech entrepreneurs up and down the country, providing them with the capital and the expertise they need to level up and grow their businesses.